Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Filed with BSE · · 3 pages · English and Hindi
Summary by 6ix AI
Titan Biotech Limited has filed a notice regarding the loss of share certificates under the relevant regulations, informing the stock exchange and shareholders about the situation. The notice includes details of the lost certificates and the process for claiming duplicates, emphasizing that claims must be submitted within a specified timeframe. The filing also mentions that the shares were previously transferred to the Investor Education and Protection Fund and are now being claimed back by the shareholders.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Jun 23 2026
- Closure of Trading Window
- Titan Biotech Limited Press Release Jun 01 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release May 30 2026
Later from Titan Biotech
- Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30, 2026.
- Titan Biotech Limited Press Release Aug 05 2026
- Unaudited Financial Results For Quarter Ended June 2026
- Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026
- Titan Biotech Limited Press Release Aug 13 2026
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech